{"id":8783,"date":"2022-01-05T17:47:01","date_gmt":"2022-01-05T17:47:01","guid":{"rendered":"https:\/\/amarintech.com\/?p=8783"},"modified":"2025-12-09T13:58:34","modified_gmt":"2025-12-09T13:58:34","slug":"sergio-lucero-amarin-differentiates-itself-by-respecting-all-the-rules-and-being-flexible-in-dealing","status":"publish","type":"post","link":"https:\/\/amarintech.com\/es\/sergio-lucero-amarin-differentiates-itself-by-respecting-all-the-rules-and-being-flexible-in-dealing\/","title":{"rendered":"Sergio Lucero: \u201cAmarin differentiates itself by respecting all the rules and being flexible in dealing\u201d"},"content":{"rendered":"
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t
<\/div>\n\t\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t\t
<\/div>\n\t\t\t\t\t\t
\n\t\t\t\n\t\n\t\n\t\n<\/svg>\t\t<\/div>\n\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t

Sergio Lucero: \u201cAmarin differentiates itself by respecting all the rules and being flexible in dealing\u201d<\/h1>\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

What makes it possible for Amarin, a small player, to compete in the big leagues of the transdermal market? Here are the reasons in the voice of our Director & CEO, Sergio Lucero.<\/strong><\/em><\/p>

Lucero is one of Amarin’s founding partners. In this article he tells us how commercial success goes hand in hand with the company’s values and the importance of the human team. He also tells us what are the objectives for the future.<\/p>

His testimony will help us appreciate the importance of passion in business and how it has influenced Amarin’s place in the transdermal market today.<\/p>

Enjoy!<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t\t\t\t\t\t

About Sergio Lucero\u00a0\u00a0 <\/strong><\/h2>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Sergio Lucero is a Certified Public Accountant who graduated from the University of Buenos Aires. Throughout his career, he has been dedicated to Foreign Trade and\/or Business Development.<\/p>

He has been working in the pharmaceutical industry for 38 years. He began his career in 1983, as Head of the Import-Export Department of Laboratorios Beta S.A. Between 1985-1991, he worked as Operations Manager of Farmac\u00e9utica Uruguaya S.A. in Montevideo (Uruguay). Upon his return to Buenos Aires in 1992, he held the position of International Operations Director of Laboratorios Beta S.A. until 1996.<\/p>

In that year, he was in charge of the negotiations for the incorporation of Ethical Pharmaceuticals Argentina SA. A company that was born under the “spin-off” model, where the Ethical UK, bought the transdermal sector of Laboratorios Beta. Due to his restless spirit, Sergio’s work became important until he became the Business Development Manager of the English company.\u00a0<\/p>

In mid-2001, Ethical UK asked him to find a buyer for the Argentina site. At that moment, he proposed to the senior scientists of the laboratory, Dr. Stefano<\/a> and Dr. Gabach, that the three of them, as managers, buy the shares from the company. Thus Amarin Technologies S.A. was born.<\/p>

In 2004, he got Amarin and the German company Helm AG of Hamburg to partner in the development of the Fentanyl patch. In this project, Lucero supervised the construction of the production plant in La Rioja, which on August 15, 2006, received the GMP certificate from the European authority.<\/p>

With his transparent negotiations, and overcoming cultural differences, Sergio managed to forge a bond of trust with Helm AG. As a result in 2010, the European company became a shareholder of Amarin.<\/p>

Today, he is Director & CEO of Amarin Technologies S.A. and its majority individual shareholder.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t\t\t\t\t\t

Amarin, a small player in the big leagues<\/strong><\/h2>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Amarin, the first company to develop transdermal patches in South America, has earned a place among the major companies in the sector worldwide.<\/p>

\u00a0<\/p>

In this aspect Lucero highlights “Amarin is proudly part of this group and being, I believe, the smallest player, the one with the smallest number of people (36). There are companies dedicated to this that have a development and research team of much more than 36 people, (…) <\/em>That is why we are very proud of our achievements”. <\/em><\/p>

\u00a0<\/p>

One of the keys that have allowed Amarin to belong to this group is professionalism. In this regard, Lucero points out that his team “holds discussions with first-world companies on an equal footing”.<\/em>\u00a0 At the same time, he confesses: “The only thing I might envy these companies is the economic resources they have”.<\/em><\/p>

\u00a0<\/p>

\u00a0<\/p>

“It is important that the companies we have contact with know that in Argentina exists <\/strong>Amarin, a reliable company that offers an excellent service in topicals and transdermals with a very good professional team<\/strong>“.<\/strong><\/h3>

\u00a0 Sergio Lucero\u00a0<\/p>

\u00a0<\/p>

Another key is flexibility and adaptability to the client. Amarin is characterized by “being respectful and complying with all international regulations on the technical side, but complementing it with a flexible attitude in dealing with customers”<\/em>. Because “large companies have their corporate schemes and it is difficult for them to adjust to the needs of each client”.<\/em><\/p>

\u00a0<\/p>

He confesses that being in Buenos Aires, Latin America could be a competitive disadvantage with respect to companies located in Europe or the USA. In this context, he says: “many companies may prefer other companies that are larger or offer a better-known name, because they may think that they are more regulated or better”<\/em>. However, he says that by focusing on their own advantages and working with international standards, they have been able to overcome this prejudice.<\/p>

\u00a0<\/p>

\u00a0<\/strong><\/p>

The importance of the human factor in transdermal development<\/strong><\/h2>

For Amarin, it is not just a matter of achieving the desired product, but of making the process transparent and constructive. This is possible thanks to the team and the values they embody.<\/p>

\u00a0<\/p>